����ֱ����Ƶ

There have been several large trials evaluating MDA with Ivermectin for malaria control over the last several years. In this seminar we present the results of several trials, and discuss the implications of these findings on use of Ivermectin MDA in control programmes. Presentations will include the BOHEMIA, MATAMAL, RIMDAMAL 2 and MASSIV trials.

Speakers

Anna Last

Anna Last is an clinician academic in the Clinical Research Department at LSHTM with research interests in the transmission and elimination of malaria and neglected tropical diseases (NTDs). She currently leads field-based cluster randomised trials in East and West Africa designing and evaluating the implementation and impact of novel tools and community-based intervention packages towards the elimination of these diseases.

Sunil Parikh

Sunil Parikh is a Professor of Epidemiology and Medicine and the Yale School of Public Health. He is an Infectious Diseases trained physician-scientist, and has been conducting translational studies of malaria in sub-Saharan Africa for over 2 decades. His group focuses on assessing existing and novel interventions for the control of malaria in high transmission settings.”

Harouna Dit Massire Soumare

Harouna Dit Massire Soumare is Medical Entomologist, and entomology laboratory manager. He is a final year PhD candidate his  work focusses on understanding the human malaria infectious reservoir and potential targeted control interventions to inform elimination.

Carlos Chaccour

Carlos Chaccour (TMIH/DTM&H 2008) is a global health physician and researcher with field experience in the Venezuelan Amazon and Mozambique. He has led research projects in DR Congo, Kenya, Mozambique and Tanzania. He has worked with the endectocide concept since 2008 and recently finished the conduction of two large-scale cluster-randomized trials on the topic under the Unitaid-funded BOHEMIA grant.

Edgard Dabira

Edgard Dabira, MD, MSc, PhD – I am a Clinical Epidemiologist with over 10 years of experience in malaria research. My work focuses on designing and implementing malaria research projects, including clinical trials aimed at accelerating malaria transmission interruption and supporting malaria control and elimination efforts in The Gambia and beyond.  Currently, I am coordinating the implementation of a multi-centre cluster-randomised trial on mass vaccination with R21/Matrix M, the recently WHO-recommended malaria vaccine. 

Event notices

• Please note that you can join this event in person or you can join the session remotely
• Please note that the recording link will be listed on this page when available.